That is the issue that will continue post-Full TLD and post JAMA but there’s nothing to be done except take anything management says with a grain of salt and mentally add a few weeks or months to any time frame and thereby avoid disappointment.
It is what it is at this point and short of a buyout nothing will change with the lack of consistent and timely follow through.
I guess we can just take advantage of yet another buying opportunity and protracted knowledge differential.